Suntrust Banks’s Charles River Laboratories CRL Stock Holding History

Suntrust Banks’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$980K	Buy	7,403 +665	+10%	+$89.2K	0.01%	748
2019 Q2	$956K	Buy	6,738 +934	+16%	+$127K	0.01%	791
2019 Q1	$844K	Sell	5,804 -2,651	-31%	-$348K	﹤0.01%	809
2018 Q4	$957K	Buy	8,455 +123	+1%	+$15.4K	0.01%	721
2018 Q3	$1.12M	Buy	8,332 +2,091	+34%	+$258K	0.01%	715
2018 Q2	$701K	Sell	6,241 -45	-0.7%	-$4.87K	﹤0.01%	826
2018 Q1	$671K	Buy	6,286 +751	+14%	+$81K	﹤0.01%	820
2017 Q4	$607K	Buy	5,535 +183	+3%	+$19.9K	﹤0.01%	826
2017 Q3	$579K	Sell	5,352 -156	-3%	-$16K	﹤0.01%	849
2017 Q2	$557K	Sell	5,508 -408	-7%	-$37.6K	﹤0.01%	821
2017 Q1	$532K	Buy	5,916 +196	+3%	+$16.6K	﹤0.01%	820
2016 Q4	$435K	Buy	5,720 +12	+0.2%	+$911	﹤0.01%	1061
2016 Q3	$475K	Sell	5,708 -86	-1%	-$7.21K	﹤0.01%	979
2016 Q2	$477K	Buy	5,794 +1,300	+29%	+$107K	﹤0.01%	972
2016 Q1	$340K	Sell	4,494 -682	-13%	-$50.5K	﹤0.01%	1073
2015 Q4	$415K	Hold	5,176	–	–	﹤0.01%	1003
2015 Q3	$327K	Hold	5,176	–	–	﹤0.01%	982
2015 Q2	$363K	Sell	5,176 -284	-5%	-$21K	﹤0.01%	951
2015 Q1	$432K	Hold	5,460	–	–	﹤0.01%	875
2014 Q4	$347K	Sell	5,460 -72	-1%	-$4.51K	﹤0.01%	926
2014 Q3	$329K	Sell	5,532 -30	-0.5%	-$1.72K	﹤0.01%	1124
2014 Q2	$296K	Sell	5,562 -7,239	-57%	-$397K	﹤0.01%	1211
2014 Q1	$770K	Buy	12,801 +1,429	+13%	+$83.3K	﹤0.01%	1101
2013 Q4	$600K	Buy	11,372 +1,417	+14%	+$71.2K	﹤0.01%	1168
2013 Q3	$458K	Buy	9,955 +1,586	+19%	+$72.8K	﹤0.01%	1269
2013 Q2	$341K	Buy	+8,369	New	+$359K	﹤0.01%	1351

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Suntrust Banks's CRL Position: Q3 2019 in Review

Suntrust Banks increased its Charles River Laboratories (CRL) stake by 9.9% in Q3 2019, buying an estimated $89.2K and bringing the position to 7,403 shares worth $980K. The position accounts for 0.01% of the portfolio, ranked #748.

Suntrust Banks first reported a position in CRL in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.12M in Q3 2018. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

Suntrust Banks held 7,403 shares of Charles River Laboratories worth $980K as of Q3 2019.
Suntrust Banks bought 665 Charles River Laboratories shares in Q3 2019, an estimated $89.2K.
Charles River Laboratories made up 0.01% of Suntrust Banks's portfolio in Q3 2019, its #748 holding.
Suntrust Banks first reported a position in Charles River Laboratories in Q2 2013 and has held it in 26 quarters since.
Suntrust Banks's Charles River Laboratories position peaked at $1.12M in Q3 2018.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.